Compare HOPE & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOPE | PRGO |
|---|---|---|
| Founded | 1986 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2000 | 2013 |
| Metric | HOPE | PRGO |
|---|---|---|
| Price | $13.43 | $14.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $15.50 | ★ $16.50 |
| AVG Volume (30 Days) | 666.2K | ★ 2.4M |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | 4.21% | ★ 7.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $24.46 | N/A |
| Revenue Next Year | $22.15 | $0.74 |
| P/E Ratio | $27.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $9.23 |
| 52 Week High | $14.59 | $22.65 |
| Indicator | HOPE | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 29.17 | 57.97 |
| Support Level | $13.09 | $13.37 |
| Resistance Level | $13.29 | $15.06 |
| Average True Range (ATR) | 0.26 | 0.61 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 2.70 | 62.60 |
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services, and other banking services.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.